We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.

Delisted

BDSI was delisted on the 22nd of March, 2022.

68 hedge funds and large institutions have $133M invested in BioDelivery Sciences International, Inc. in 2013 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 28 increasing their positions, 12 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 12

112% more call options, than puts

Call options by funds: $36K | Put options by funds: $17K

48% more capital invested

Capital invested by funds: $90M → $133M (+$43.4M)

1% more funds holding

Funds holding: 6768 (+1)

9% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 11

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
68
Holders Change
+1
Holders Change %
+1.49%
% of All Funds
2.2%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
12
Increased
28
Reduced
12
Closed
11
Calls
$36K
Puts
$17K
Net Calls
+$19K
Net Calls Change
-$14K
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$30.9M +$2.42M +503,000 +10%
DM
2
Deerfield Management
New York
$14.2M
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$12.5M
BC
4
Broadfin Capital
New York
$11.5M
SC
5
Sophrosyne Capital
New York
$8.01M
BIT
6
BlackRock Institutional Trust
California
$6.7M +$95.4K +19,852 +2%
VAM
7
Visium Asset Management
New York
$5.97M +$5.29M +1,100,000 New
BBA
8
Baker Bros. Advisors
New York
$4.59M -$262K -54,500 -6%
BFA
9
BlackRock Fund Advisors
California
$4.59M +$473K +98,300 +13%
TAM
10
THB Asset Management
Connecticut
$4.38M +$121K +25,250 +3%
Vanguard Group
11
Vanguard Group
Pennsylvania
$4.32M +$263K +54,678 +7%
Federated Hermes
12
Federated Hermes
Pennsylvania
$3.08M +$2.72M +566,409 New
CM
13
Castleark Management
Illinois
$2.87M +$808K +168,125 New
Northern Trust
14
Northern Trust
Illinois
$2.32M +$505K +105,122 +33%
State Street
15
State Street
Massachusetts
$2.01M +$12.3K +2,565 +0.7%
KCM
16
Kennedy Capital Management
Missouri
$1.63M +$357K +74,237 +33%
Allianz Asset Management
17
Allianz Asset Management
Germany
$1.27M +$1.12M +233,955 New
SKK
18
Shepherd Kaplan Krochuk
Massachusetts
$1.17M +$260K +54,115 +33%
Deutsche Bank
19
Deutsche Bank
Germany
$889K +$235K +48,780 +42%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$874K +$114K +23,705 +17%
LOM
21
Loeb Offshore Management
New York
$872K +$583K +121,280 +309%
JP Morgan Chase
22
JP Morgan Chase
New York
$814K +$93K +19,354 +15%
TAM
23
Tocqueville Asset Management
New York
$798K +$120K +25,000 +20%
TCIM
24
TIAA CREF Investment Management
New York
$763K -$176K -36,676 -21%
Geode Capital Management
25
Geode Capital Management
Massachusetts
$619K +$16.5K +3,438 +3%

BDSI Hedge Fund Activity: Q3 2013 in Review

68 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q3 2013, worth a combined $133M — up 48% from $90M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new BDSI positions and 11 closed out — a net gain of 1 holder — while 28 added to existing stakes and 12 trimmed.

The largest buyer was Visium Asset Management, opening a new position worth an estimated $5.29M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $1.94M sold.

  • 68 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q3 2013, up from 67 in Q2 2013.
  • Funds reported $133M of BioDelivery Sciences International, Inc. stock for Q3 2013, up 48% quarter-over-quarter.
  • 12 funds opened new BioDelivery Sciences International, Inc. positions in Q3 2013 and 11 closed out, a net change of +1 holder.
  • The largest BioDelivery Sciences International, Inc. buyer in Q3 2013 was Visium Asset Management, an estimated $5.29M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q3 2013 was Perceptive Advisors, an estimated $1.94M sold.

Based on aggregated 13F filings for Q3 2013.